Contents
1. The race against breast cancer
   
2.

What's new in breast cancer research?

The truth about Herceptin

   
3.

Radiotherapy in breast cancer treatment

Nuts and bolts of mammography

   
4.

PET-CT in oncology

Role of prophylactic mastectomy in breast cancer

   
5.

Breast conservation and breast reconstruction

Genetics of breast cancer

   
6.

Risk assessment and chemoprevention

Hormone receptors in breast cancer - from bench to bedside

   
  NCC Tumour Board Files
   
  Onco Quiz
   
  NCC Roundup
   
 

Pharmacy Tips

   
  Breast Cancer Overview
   
  Staff Directory
   
  Contact
   

 

 

Top

 

NCC Round Up
 
International journals publish NCC research
The Biophotonics, an international journal for photonics solutions in biotechnology and medicine, has in its May issue, highlighted the work of researchers from NCC and SGH (Zheng W, Lau W, Cheng C, Soo KC and Olivo M, International Journal of Cancer, vol. 104, 477-481, 2003). The paper, mentioned in Biophotonics, examined the use of laser-induced fluorescence in early detection of recurrent bladder cancer, which is otherwise hard to detect visually. The method is also useful in initial diagnosis of individuals at high risk of developing bladder cancer.

NCC Principal Investigator, Dr Philip Karuman's work was also published. As the first co-author of a paper published in Cell, he and a team of scientists (from US, France and Netherlands) identified a new phosphoinositide receptor (vol. 114, 99-111, 2003). Phosphoinositides are important for growth regulation, survival and proliferation of cells. His research has contributed to the understanding of how cells can become malignant at the molecular level.

New computer software for genetic profiling
NCC scientists and researchers have collaborated with Genedata to achieve better research results when analysing gene expressions in cancers. Genedata specialises in developing a computer software system Expressionist™, which identifies different tumour subtypes, based on genetic profiling called microarray. As pathologically similar solid tumours of the same organ-type may have different genetic profiles, the use of Expressionist™ will improve prognostication and prediction of tumour response to treatment.

NCC researchers win awards
Researchers Ong Choon Kiat and Caine Leong won first and second prize for Best Presentation respectively at the Graduate Student Society - Faculty of Medicine 3rd annual scientific conference organised by National University of Singapore, on 4 July 2003. Their work on a gene structure related to carcinogenesis of renal cancers, and a protein that is over-expressed in ovarian cancers, won unanimous acclaim from the judges.

The American Association for Cancer Research (AACR) Avon International Scholar-in-Training Award was awarded to Caine Leong for his poster on Molecular Cloning and Characterisation of a Putative Oncogene in Ovarian Carcinogenesis.


BreastScreen Singapore
The Health Promotion Board (HPB), as part of BreastScreen Singapore Project, will be organising the second multi-disciplinary seminar, 'Striding into the second year: Progress and Updates', on 8-9 November, 2003. The seminar is aimed at pathologists, radiographers, surgeons, nurses and other medical professionals involved in breast screening work. Distinguished local and foreign guest speakers from UK and Australia will update the audience on the BreastScreen project and share expert knowledge on breast cancer screening. All lectures will be held in the HPB auditorium, except radiology workshops, which will be held in Tan Tock Seng Hospital.

NCC bags multiple research grants
Please visit www.nccs.com.sg/epub/cu/vol3_03/Rnd_up.htm for the grants list awarded to NCC investigators for various research projects.



NCC fights SARS with vigilance


SARS was a medical 'event' that affected many healthcare workers in Singapore. Cancer Update spoke to Dr Khoo Kei Siong, Chairman of SARS Task Force (NCC), to find out how NCC coped with SARS.

Dr Khoo believes that protection, detection, isolation and constant vigil are the central tenets that NCC should stick to for containing a possible outbreak.  

Log onto:
www.nccs.com.sg/epub/cu/vol3_03/lead_SARS.htm to read about Dr Khoo's answers to the following questions:

  • What are the measures NCC has implemented to fight SARS?
  • Will NCC continue with these measures even though Singapore is off the WHO SARS list?
  • Are cancer patients more prone to catch SARS or to spread it?
  • Fever and coughing are common symptoms that cancer patients have. How do we differentiate these symptoms from SARS?
  • When do we stop implementing the measures?